• 제목/요약/키워드: Systemic inflammation

검색결과 300건 처리시간 0.022초

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions

  • Hanna Klingel;Alexander Kruttgen;Matthias Imohl;Michael Kleines
    • Clinical and Experimental Vaccine Research
    • /
    • 제12권1호
    • /
    • pp.60-69
    • /
    • 2023
  • Purpose: Although the fast development of safe and effective messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 has been a success, waning humoral immunity has led to the recommendation of booster immunization. However, knowledge of the humoral immune response to different booster strategies and the association with adverse reactions is limited. Materials and Methods: We investigated adverse reactions and anti-spike protein immunoglobulin G (IgG) concentrations among health care workers who received primary immunization with mRNA-1273 and booster immunization with mRNA-1273 or BNT162b2. Results: Adverse reactions were reported by 85.1% after the first dose, 94.7% after the second dose, 87.5% after a third dose of BNT162b2, and 86.0% after a third dose of mRNA-1273. They lasted for a median of 1.8, 2.0, 2.5, and 1.8 days, respectively; 6.4%, 43.6%, and 21.0% of the participants were unable to work after the first, second, and third vaccination, respectively, which should be considered when scheduling vaccinations among essential workers. Booster immunization induced a 13.75-fold (interquartile range, 9.30-24.47) increase of anti-spike protein IgG concentrations with significantly higher concentrations after homologous compared to heterologous vaccination. We found an association between fever, chills, and arthralgia after the second vaccination and anti-spike protein IgG concentrations indicating a linkage between adverse reactions, inflammation, and humoral immune response. Conclusion: Further investigations should focus on the possible advantages of homologous and heterologous booster vaccinations and their capability of stimulating memory B-cells. Additionally, understanding inflammatory processes induced by mRNA vaccines might help to improve reactogenicity while maintaining immunogenicity and efficacy.

후복막강에 발생한 Immunoglobulin G4 연관 질환의 비전형적 발현: 증례 보고 (Unusual Manifestation of Immunoglobulin G4-Related Disease Involving the Retroperitoneum: A Case Report)

  • 김병수;서정욱
    • 대한영상의학회지
    • /
    • 제82권2호
    • /
    • pp.487-492
    • /
    • 2021
  • Immunoglobulin G4 (이하 IgG4)연관 질환은 풍부한 IgG4 형질세포 형태의 림프형질 세포 침윤과 현저한 섬유아세포 증식을 특징으로 하는 전신 질환이다. 일반적으로 IgG4 연관 질환의 후복막강 발현은 복부 대동맥을 둘러싸거나, 요관을 압박하여 수신증을 일으키는 연조직의 형태로 나타난다. 우리는 75세 여성 환자에서 발생한 비전형적인 IgG4 연관 질환의 후복막강 발현에 대해 보고하고자 한다. 수술 전 전산화단층촬영에서 정상 해부학적 경계를 넘어서는 침윤성 성질을 가진 불규칙한 형태의 후복막강의 종괴가 관찰되었으며, 이는 악성 혹은 염증성 상태가 의심되었다. 조영증강 촬영에서 종괴는 균일한 점진적인 조영증강을 보였다.

폐혈관염의 영상의학적 접근 (Radiologic Approach for Pulmonary Vasculitis)

  • 김초희;김윤경;한정호
    • 대한영상의학회지
    • /
    • 제82권4호
    • /
    • pp.791-807
    • /
    • 2021
  • 혈관염은 혈관벽의 염증을 특징으로 하는 드문 전신 질환으로 간혹 미만성 폐출혈이나 급성사구체신염으로 생명을 위협하기도 한다. 원인을 알 수 없는 일차성 혈관염도 있지만 자가면역 질환이나 약물, 감염, 종양 등 수많은 원인들에 의해 발생하는 이차성 혈관염도 있으며 분류가 복잡하고 명확한 진단검사가 없어 진단에 어려움이 있다. 또한 다양하고 비특이적인 증상과 징후 및 검사 소견을 보여 혈관염의 진단에는 임상양상, 영상 검사, 자가항체 검사, 병리소견 등 여러 가지 결과를 종합하는 것이 필수적이다. 이 종설에서는 혈관염의 분류와 진단에 중요한 증상 및 징후, 특징적으로 폐를 침범하는 대표적인 폐혈관염의 영상 소견과 감별진단, 그리고 새로운 혈관염 분류를 위한 국제적 연구인 Diagnostic and Classification Criteria in Vasculitis에 대해 소개하고자 한다.

상완에 발생한 면역글로불린 G4 연관 질환의 비전형적 발현: 증례 보고 (Unusual Manifestation of Immunoglobulin G4-Related Disease Involving the Upper Arm: A Case Report)

  • 박진희;이선주;추혜정
    • 대한영상의학회지
    • /
    • 제84권3호
    • /
    • pp.719-725
    • /
    • 2023
  • 면역글로불린 G4(immunoglobulin G4; 이하 IgG4) 관련 질환은 드문 전신성 섬유염증 상태로 IgG4 형질 세포가 풍부한 림프구 침윤과 관련된 기관 비대 또는 종창성 병변을 특징으로 한다. 우리는 48세 여자 환자에서 드문 소견인 연조직 종괴로 발현된 왼팔의 피하층을 침범한 IgG4 관련 질환 증례를 보고하고자 한다. 초음파 및 자기공명영상을 촬영하였으며 악성 또는 염증 병변이 의심되는 불규칙하며 침윤성 경계를 갖는 연조직 종괴가 관찰되었다. 우리는 IgG4 관련 질환의 진단 기준, 조직 병리학적 특징, 영상의학적 특징, 및 치료 방법에 대해 논의하고자 한다.

Catechin hydrate prevents cisplatin-induced spermatogonia GC-1 spg cellular damage

  • Hyeon Woo Shim;Won-Yong Lee;Youn-Kyung Ham;Sung Don Lim;Sun-Goo Hwang;Hyun-Jung Park
    • 한국동물생명공학회지
    • /
    • 제39권2호
    • /
    • pp.145-152
    • /
    • 2024
  • Background: Despite its anticancer activity, cisplatin exhibits severe testicular toxicity when used in chemotherapy. Owing to its wide application in cancer therapy, the reduction of damage to normal tissue is of imminent clinical need. In this study, we evaluated the effects of catechin hydrate, a natural flavon-3-ol phytochemical, on cisplatin-induced testicular injury. Methods: Type 2 mouse spermatogonia (GC-1 spg cells) were treated with 0-100 μM catechin and cisplatin. Cell survival was estimated using a cell proliferation assay and Ki-67 immunostaining. Apoptosis was assessed via flow cytometry with the Dead Cell Apoptosis assay. To determine the antioxidant effects of catechin hydrate, Nrf2 expression was measured using qPCR and CellROX staining. The anti-inflammatory effects were evaluated by analyzing the gene and protein expression levels of iNOS and COX2 using qPCR and immunoblotting. Results: The 100 μM catechin hydrate treatment did not affect healthy GC-1 spg cells but, prevented cisplatin-induced GC-1 spg cell death via the regulation of anti-oxidants and inflammation-related molecules. In addition, the number of apoptotic cells, cleaved-caspase 3 level, and BAX gene expression levels were significantly reduced by catechin hydrate treatment in a cisplatin-induced GC-1 spg cell death model. In addition, antioxidant and anti-inflammatory marker genes, including Nrf2, iNOS, and COX2 were significantly downregulated by catechin hydrate treatment in cisplatintreated GC-1 cells. Conclusions: Our study contributes to the opportunity to reintroduce cisplatin into systemic anticancer treatment, with reduced testicular toxicity and restored fertility.

소아 특발성 간질성 폐렴 1례 (A Case of Idiopathic Interstitial Pneumonia in Childhood)

  • 이수진;신언우;박은영;오필수;이건희;김광남;신호승;이일성
    • Clinical and Experimental Pediatrics
    • /
    • 제48권3호
    • /
    • pp.327-332
    • /
    • 2005
  • 저자들은 내원 1개월 전부터 시작된 잦은 마른기침, 운동 시 호흡곤란, 8 kg의 급속한 체중 감소가 주 증상인 8세 남아에서 특발성 간질성 폐렴으로 진단하고, 경구용 프레드니손으로 치료한 후 1년 이상 추적 관찰하여 현재 학교에서 가벼운 체육활동을 할 수 있을 정도의 임상적 호전을 보인 1례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

What is the meaning of hs-CRP and HbA1c in patients with dry eye syndrome in diabetes?

  • Kang, Ji-Hun;Shin, Sang-Yol
    • 한국컴퓨터정보학회논문지
    • /
    • 제25권3호
    • /
    • pp.185-190
    • /
    • 2020
  • 본 연구는 2016년 6월 16일부터 2016년 12월 31일까지 건강검진센터를 방문한 726명을 대상으로 Schirmer's 검사와 대사증후군 검사를 통해 전신적 만성 염증성 상태가 국소적 만성 염증성 상태로서의 안구건조증에 미치는 영향을 알아보고자 시행하였다. 대상자중 hs-CRP, HbA1c를 동시 측정한 214명을 대상으로 연구를 진행하였다. 연구대상자 중 고 연령일수록 (p<0.001), 성별로는 여성에서 유의하게 안구건조증이 증가하였으며(p=0.020), 공복혈당과 hs-CRP와는 연관이 없었다. 또한 HbA1c가 증가할수록 안구건조증에 대한 위험도가 증가하였다(β=1.960, p=0.025). 따라서 안구건조증은 만성 염증성 상태로 인한 눈물샘의 미세혈관 변화에 의한 것이 아니며 당뇨환자의 경우 단기간의 혈당 조절보다 장기간의 혈당 조절상태가 더욱 중요하게 작용할 수 있음을 알 수 있으며 당뇨병 환자에서 안구 건조증의 높은 유병률은 만성 염증으로 인한 미세 혈관 변화보다는 자율 기능 장애로 인한 것으로 생각된다.

Sprague-Dawley Rats을 이용한 결명자 물 추출물의 26주 반복 경구투여 독성시험 및 4주 회복시험 (A 26-Week Repeated Oral Dose Toxicity Test and a 4-Week Recovery Test of Cassia tora L. Water Extract in Sprague-Dawley Rats)

  • 노종현;이무진;정호경;장지훈;심미옥;장민철;용주현;서형식;안병관;김종춘;조현우
    • 한국약용작물학회지
    • /
    • 제26권2호
    • /
    • pp.157-169
    • /
    • 2018
  • Background: Cassia tora L., an annual or perennial plant of the Fabaceae family, is traditional medicine with various biological activities, including anti-constipation and, anti-inflammation. Chemical compounds such as anthraquinone glycoside and naphthalene derivatives have been isolated from this plant. Cassia tora L. is a common contaminant of agricultural commodities, but is toxic to cattle and poultry. Methods and Results: To investigate the potential toxicity, Cassia tora L. aqueous extract (CO) was administered orally to rats for 26 weeks at 0 (control), 300, 1,500 and 3,000 mg/kg/day (n = 10 for male rats for each dose). The positive control comprised animals orally administered anthraquinone 100 mg/kg/day. There was no treatment-related mortality. An increase in the kidney weight was observed at 3,000 mg/kg/day of CO and anthraquinone 100 mg/kg/day. Macrophage infiltration in the colon was observed at CO 1,500 and 3,000 mg/kg/day and anthraquinone 100 mg/kg/day, but there were no significant toxicological changes in the incidence and severity of the finding. Conclusions: The oral no-observed-adverse-effect level (NOAEL) of CO was 3,000 mg/kg/day in male rats and no target organs were identified. In addition, 300 mg/kg was found to be the no-observed-effect level (NOEL) for systemic toxicity under the conditions of the study.

AIDS 침구(鍼灸) 치료(治療)에 대한 최근 정보 검색 (Recent Data Search for Acupuncture and Moxibustion Therapy on Acquired Immune Deficiency Syndrome(AIDS))

  • 송호섭;임정은;권순정;이성노;황현서;김기현
    • Journal of Acupuncture Research
    • /
    • 제18권3호
    • /
    • pp.154-170
    • /
    • 2001
  • Objective : To broaden understanding about acupuncture and moxibustion therapy on AIDS and to promote base studies and clinical trials Materials and Methods : Analysis was given to more than 30 literatures including acupuncture and moxibustion therapy on AIDS-related sites explored by internet search engine named NAVER from Nov., 2000 to Feb. 20th, 2001 Results : 1. Acupuncture and moxibustion played great role as a complementary therapy in enabling AIDS patients to keep their antiretroviral therapy by enhancing immune system, ameliorating AIDS-related symptoms and side effect of antiretroviral drug 2. Acupuncture and moxibustion therapy had a broad spectrum indication from systemic or local signs of AIDS patients to signs of antiretroviral drug-related side effect 3. Contraindication of acupuncture and moxibustion therapy against AIDS patients include abstraction and moxibustion on the skin lesion, because of their easy exposure to inflammation 4. AIDS patients were regarded as the state of KI-HE(氣虛), EUM-HE(陰虛), YEOL-DOK(熱毒) in general 5. BO-KI(補氣), BO-HYUL(補血), BO-EUM(補陰), CHEONG-YEOL-HAE-DOK(淸熱解毒) were shown as a principle of acupuncture and moxibustion therapy for AIDS patients 6. Principle of selecting acupoints for AIDS patients had characteristics of enhancing immune system, detoxicating detrimental agents and relieving each AIDS related symptom appropriately 7. Acupuncture on 合谷(HAPKOK, LI4), 內關(NAE-GWAN, P6), 足三里(CHOK-SAMNI, S36) were applied to the early stage of AIDS in order to enhance immune system. Acupuncture on 血海(HYOLHAE, SP10), 三陰交(SAMUMGYO, SP6), (KOHWANG, B43) were applied to the intermediate stage of AIDS so as to enhance immune system and eliminate YEOL-DOK(熱毒) in blood. Moxibustion on 湧泉(YONGCHON, K1), 足三里(CHOK-SAMNI, S36) were applied to the late stage owing to enhance immune system more. Conclusion : The efficacy of acupuncture and moxibustion therapy on AIDS has been acknowledged to the world, moreover, it is proved to be significant as a complementary therapy on AIDS patients. Thus, more control group studies of the efficacy of acupuncture and moxibustion therapy on AIDS and clinical trials are considered to be necessary.

  • PDF

단순 만성 치주염 환자와 제 2형 당뇨병을 동반한 만성 치주염 환자에서 Stromelysin-1와 Membrane type-MMP-1 Expressions (Stromelysin-1 and Membrane type-MMP-1 Expressions in Human Chronic Periodontitis with Type 2 Diabetes Mellitus)

  • 류상호;박진우;서조영;이재목
    • Journal of Periodontal and Implant Science
    • /
    • 제38권4호
    • /
    • pp.629-638
    • /
    • 2008
  • Purpose: The purposes of this study were to compare and quantify the expression of Stromelysin-1 and MT-MMP-1 in the gingival tissues of patients with type 2 diabetes mellitus(DM) and healthy adults with chronic periodontitis. Materials and Methods: Gingival tissue samples were obtained during periodontal surgery or tooth extraction. According to the patient's systemic condition & clinical criteria of gingiva, each gingival sample was devided into three groups. Group 1 (n=8) is clinically healthy gingiva without bleeding and no evidence of bone resorption or periodontal pockets, obtained from systemically healthy 8 patients. Group 2 (n=8) is inflammed gingiva from patients with chronic periodontitis. Group 3 (n=8) is inflammed gingiva from patients with chronic periodontitis associated with type 2 DM. Tissue samples were prepared and analyzed by Western blotting. The quantification of Stromelysin-1 and MT-MMP-1 were performed using a densitometer and statistically analyzed by one-way ANOVA followed by Tukey test. Results: In the analysis of expression levels, Stromelysin-1 and MT-MMP-1 expressions were similar in group 1 and 2. Stromelysin-1 and MT-MMP-1 expressions was more increased in group 3 than group 1, 2. The difference between group 3 and group 1, 2 was statistically significant. Also, in the interrelationship of Stromelysin-1 and MT-MMP-1 expressions, expressions of Stromelysin-1 and MT-MMP-1 showed increasing tendency in chronic periodontitis associated with type 2 DM and it seems that the MT-MMP-1 expressions were increasing in proportion to Stromelysin-1 expressions. Conclusion: It is suggested that Stromelysin-1 and MT-MMP-1 may be partly involved in the progression of periodontal inflammation associated with type 2 DM, as related to a metabolism of other factors, such as AGE, plasmin and other inflammatory mediators. Therefore, the expression levels of Stromelysin-1 and MT-MMP-1 can be inflammatory markers of periodontal inflammed tissue with type 2 DM.